Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis

Autor: Miguel Foronda, Miguel A. del Pozo, Raffaele Strippoli, Maria Teresa Osteso, Jesús Loureiro, Susana Minguet, Olga Barreiro, Maria Luisa Lozano, Vanessa Moreno, Enrique Calvo, Teijo Pellinen, Manuel López Cabrera, Ignacio Benedicto, Jesús Vázquez
Přispěvatelé: Ministerio de Economía y Competitividad (España), Fundacio la Marato, Instituto de Salud Carlos III, Centro de Investigación Biomedica en Red - CIBERA97, Ministerio de Ciencia e Innovación (España), Fundación ProCNIC, Institute for Molecular Medicine Finland, Precision Systems Medicine
Jazyk: angličtina
Rok vydání: 2015
Předmět:
MAPK/ERK pathway
Pathology
Caveolin 1
NF-KAPPA-B
Smad Proteins
epithelial–mesenchymal transition
TRANSCRIPTIONAL ACTIVITY
Mice
0302 clinical medicine
Caveolin-1
Fibrosis
Laminin
Research Articles
MEK-ERK1/2- pathway
Mice
Knockout

Mitogen-Activated Protein Kinase 1
0303 health sciences
Mitogen-Activated Protein Kinase 3
biology
MEK‐ERK1/2 pathway
MESOTHELIAL CELLS
EMT
TGF-BETA
Epithelial-mesenchymal transition
3. Good health
medicine.anatomical_structure
030220 oncology & carcinogenesis
Molecular Medicine
Peritoneum
Corrigendum
medicine.medical_specialty
Epithelial-Mesenchymal Transition
SCAFFOLDING DOMAIN
MAP Kinase Signaling System
education
Peritoneal dialysis
Transforming Growth Factor beta1
03 medical and health sciences
E-CADHERIN EXPRESSION
MEK-ERK1/2 pathway
TGF beta signaling pathway
medicine
Animals
Humans
Epithelial–mesenchymal transition
QUANTITATIVE PROTEOMICS
030304 developmental biology
business.industry
Mesenchymal stem cell
fibrosis
Epithelial Cells
medicine.disease
MAP KINASE PATHWAY
ENDOTHELIAL GROWTH-FACTOR
biology.protein
Cancer research
caveolin‐1
PULMONARY DEFECTS
3111 Biomedicine
Snail Family Transcription Factors
business
Transcription Factors
Zdroj: EMBO Molecular Medicine
Repisalud
Instituto de Salud Carlos III (ISCIII)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Popis: Peritoneal dialysis (PD) is a form of renal replacement therapy whose repeated use can alter dialytic function through induction of epithelial-mesenchymal transition (EMT) and fibrosis, eventually leading to PD discontinuation. The peritoneum from Cav1(-/-) mice showed increased EMT, thickness, and fibrosis. Exposure of Cav1(-/-) mice to PD fluids further increased peritoneal membrane thickness, altered permeability, and increased the number of FSP-1/cytokeratin-positive cells invading the sub-mesothelial stroma. High-throughput quantitative proteomics revealed increased abundance of collagens, FN, and laminin, as well as proteins related to TGF-beta activity in matrices derived from Cav1(-/-) cells. Lack of Cav1 was associated with hyperactivation of a MEK-ERK1/2-Snail-1 pathway that regulated the Smad2-3/Smad1-5-8 balance. Pharmacological blockade of MEK rescued E-cadherin and ZO-1 inter-cellular junction localization, reduced fibrosis, and restored peritoneal function in Cav1(-/-) mice. Moreover, treatment of human PD-patient-derived MCs with drugs increasing Cav1 levels, as well as ectopic Cav1 expression, induced re-acquisition of epithelial features. This study demonstrates a pivotal role of Cav1 in the balance of epithelial versus mesenchymal state and suggests targets for the prevention of fibrosis during PD. We thank Dr. Kurzchalia, Dr. Pol, and Dr. Lisanti for providing us MEFs from WT and Cav1-/- mice. We thank Dr. Valeria Caiolfa, head of CNIC Microscopy unit, and Elvira Arza and Antonio Manuel Santos Beneit for technical assistance. We thank Cecilia Battistelli and Marta Loureiro Lopez por technical assistance in molecular biology and proteomics, respectively. This work was supported by grants from the MINECO (Spanish Ministry of Economy and Competitivity) to MADP (SAF2008-02100, SAF2011-25047 and CONSOLIDER CSD2009-00016) and to MLC (SAF2010-21249 and SAF2013-47611R), and from Fundacio la Marato TV3 (674/C/2013) to MADP. Raffaele Strippoli was supported by a Rio Hortega Contract (Instituto de Salud Carlos III). Ignacio Benedicto was recipient of a CIBERehd fellowship (Spanish Ministry of Health and Consumer Affairs). Susana Minguet was supported by the Ramon y Cajal program (Spanish Ministry of Science and Innovation). Simon Bartlett (CNIC) provided editorial assistance. The CNIC is supported by MINECO and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sí
Databáze: OpenAIRE